Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Detrusor Hyperreflexia”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Early research (Phase 1)Study completedNCT01539707
What this trial is testing

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Inc 14
Early research (Phase 1)Study completedNCT02526979
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 9
Large-scale testing (Phase 3)Ended earlyNCT00667095
What this trial is testing

Over Active Bladder Instillation Study - Botox

Who this might be right for
Overactive BladderUrinary Urge IncontinenceUrinary Incontinence+2 more
Mayo Clinic 25
Large-scale testing (Phase 3)Study completedNCT01981954
What this trial is testing

A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)

Who this might be right for
Neurogenic Detrusor OveractivityPediatric
Astellas Pharma Europe B.V. 23
Not applicableStudy completedNCT06059066
What this trial is testing

Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction

Who this might be right for
Neurogenic BladderLower Urinary Tract SymptomsOveractive Bladder+2 more
The Methodist Hospital Research Institute 78
Large-scale testing (Phase 3)Study completedNCT01530620
What this trial is testing

Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Urinary Bladder DisorderUrinary Bladder, NeurogenicBladder Disorder, Neurogenic+6 more
APOGEPHA Arzneimittel GmbH 66
Large-scale testing (Phase 3)UnknownNCT01050114
What this trial is testing

OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER

Who this might be right for
Overactive Bladder
Christopher Patrick Smith 36
Not applicableStudy completedNCT01226706
What this trial is testing

Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge Incontinence

Who this might be right for
Urinary Urge Incontinence
Saskatchewan Health Authority - Regina Area 21
Large-scale testing (Phase 3)Study completedNCT01091727
What this trial is testing

Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Sunnybrook Health Sciences Centre 57
Post-approval studies (Phase 4)Study completedNCT00629642
What this trial is testing

Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis

Who this might be right for
Multiple SclerosisNeurogenic BladderSpinal Cord Diseases
Astellas Pharma Inc 249
Not applicableNot Yet RecruitingNCT07695662
What this trial is testing

The Predictive Value of Lower Extremity Hypertonia on Neurogenic Detrusor Overactivity After Spinal Cord Injury

Who this might be right for
Spinal Cord Injuries (SCI)
Shengjing Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT00712322
What this trial is testing

A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Warner Chilcott 35
Not applicableLooking for participantsNCT05141487
What this trial is testing

Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder

Who this might be right for
Urinary IncontinenceUrinary Bladder, Neurogenic
VA Office of Research and Development 16
Not applicableStudy completedNCT05504200
What this trial is testing

Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training

Who this might be right for
Spinal Cord Injuries
RNOH RIC 15
Large-scale testing (Phase 3)Active Not RecruitingNCT05621616
What this trial is testing

Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Astellas Pharma Global Development, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00857896
What this trial is testing

Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Pfizer 21
Testing effectiveness (Phase 2)Study completedNCT02676154
What this trial is testing

Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)

Who this might be right for
Autonomic Dysreflexia
University of British Columbia 15
Post-approval studies (Phase 4)Study completedNCT02298660
What this trial is testing

Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI

Who this might be right for
Autonomic Dysreflexia
Rick Hansen Institute 55
Early research (Phase 1)Study completedNCT04478357
What this trial is testing

BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG

Who this might be right for
Neurogenic Detrusor Overactivity
Pfizer 18
Large-scale testing (Phase 3)Study completedNCT02751931
What this trial is testing

Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 91
Next Page